Final Guidance: Institutional Review Board (IRB) Review of Individual Patient Expanded Access Submissions for Investigational Drugs and Biological Products-2023/9/8

Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act-2025/1/7

Document: Guide to manufacturers on the procedure for requesting advice from expert panels on clinical investigations and / or clinical development strategies for high-risk medical devices-2025/2/10

Document: List of signals discussed at PRAC since September 2012-2025/3/17

国家药监局关于注销安喘片等5个品种药品注册证书的公告（2025年第39号）-2025/4/17

Document: List of signals discussed at PRAC since September 2012-2025/6/2

Document: Minutes of the PRAC meeting 5-8 May 2025-2025/7/4

Document: Vaccine Monitoring Platform: List of EMA-funded studies-2025/8/7

Page: List of medicines under additional monitoring-2025/9/24

Document: Policy 46: European Medicines Agency policy on video surveillance-2025/11/3